BridgeBio Pharma (BBIO) Inventory (2025 - 2026)
BridgeBio Pharma recorded quarterly Inventory of $33.0 million in Q1 2026, up 23.28% quarter-over-quarter from $26.8 million in Q4 2025, and up 734.09% year-over-year from $4.0 million in Q1 2025.
BridgeBio Pharma's Inventory history runs 2 years deep, the most recent figure standing at $33.0 million for Q1 2026.
- In Q1 2026, Inventory rose 734.09% year-over-year to $33.0 million; the TTM figure through Mar 2026 stood at $33.0 million (up 734.09% YoY), while the FY2025 annual figure was $26.8 million, changed N/A from the prior year.
- Inventory came in at $33.0 million for Q1 2026 at BridgeBio Pharma, up from $26.8 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $33.0 million in Q1 2026 to a low of $4.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 84.03 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | 32.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.98 Mn |
| Dec 31, 2025 | 26.75 Mn |
| Sep 30, 2025 | 24.53 Mn |
| Jun 30, 2025 | 18.28 Mn |
| Mar 31, 2025 | 3.95 Mn |